-DOCSTART- -X- O
Pertussis -X- _ O
is -X- _ O
an -X- _ O
under-recognized -X- _ O
cause -X- _ O
of -X- _ O
neonatal -X- _ O
morbidity -X- _ O
and -X- _ O
mortality. -X- _ O
To -X- _ O
review -X- _ O
information -X- _ O
on -X- _ O
the -X- _ O
epidemiology -X- _ O
and -X- _ O
disease -X- _ O
burden -X- _ O
of -X- _ O
neonatal -X- _ B-Intervention
pertussis -X- _ I-Intervention
in -X- _ O
South -X- _ B-Patient
and -X- _ I-Patient
Southeast -X- _ I-Patient
Asian -X- _ I-Patient
countries -X- _ I-Patient
, -X- _ O
a -X- _ O
systematic -X- _ O
literature -X- _ O
review -X- _ O
of -X- _ O
three -X- _ O
bibliographic -X- _ O
databases -X- _ O
was -X- _ O
undertaken. -X- _ O
Peer-reviewed -X- _ O
original -X- _ O
studies -X- _ O
on -X- _ O
neonatal -X- _ B-Intervention
pertussis -X- _ I-Intervention
epidemiology -X- _ O
and -X- _ O
burden -X- _ O
published -X- _ O
since -X- _ O
2000 -X- _ O
, -X- _ O
with -X- _ O
a -X- _ O
geographical -X- _ O
scope -X- _ O
limited -X- _ O
to -X- _ O
South -X- _ B-Patient
and -X- _ I-Patient
Southeast -X- _ I-Patient
Asian -X- _ I-Patient
countries -X- _ I-Patient
, -X- _ O
were -X- _ O
included. -X- _ O
Data -X- _ O
were -X- _ O
systematically -X- _ O
extracted -X- _ O
based -X- _ O
on -X- _ O
parameters -X- _ O
defined -X- _ O
a -X- _ O
priori. -X- _ O
Our -X- _ O
findings -X- _ O
show -X- _ O
that -X- _ O
the -X- _ O
burden -X- _ O
of -X- _ O
neonatal -X- _ B-Intervention
pertussis -X- _ I-Intervention
and -X- _ O
its -X- _ O
complications -X- _ O
is -X- _ O
substantial. -X- _ O
An -X- _ O
increase -X- _ B-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
number -X- _ I-Outcome
of -X- _ I-Outcome
pertussis -X- _ I-Outcome
cases -X- _ I-Outcome
has -X- _ I-Outcome
been -X- _ I-Outcome
noted -X- _ I-Outcome
since -X- _ I-Outcome
early -X- _ I-Outcome
2000 -X- _ I-Outcome
, -X- _ I-Outcome
ranging -X- _ I-Outcome
from -X- _ I-Outcome
61 -X- _ I-Outcome
to -X- _ I-Outcome
92.9 -X- _ I-Outcome
% -X- _ I-Outcome
in -X- _ I-Outcome
infants -X- _ I-Outcome
0–3 -X- _ I-Outcome
months -X- _ I-Outcome
old. -X- _ I-Outcome
The -X- _ I-Outcome
most -X- _ I-Outcome
common -X- _ I-Outcome
symptoms -X- _ I-Outcome
an -X- _ I-Outcome
infant -X- _ I-Outcome
is -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
present -X- _ I-Outcome
with -X- _ I-Outcome
are -X- _ I-Outcome
cough -X- _ I-Outcome
with -X- _ I-Outcome
or -X- _ I-Outcome
without -X- _ I-Outcome
paroxysms -X- _ I-Outcome
, -X- _ I-Outcome
cyanosis -X- _ I-Outcome
, -X- _ I-Outcome
apnea -X- _ I-Outcome
, -X- _ I-Outcome
tachypnea -X- _ I-Outcome
, -X- _ I-Outcome
difficulty -X- _ I-Outcome
in -X- _ I-Outcome
breathing -X- _ I-Outcome
and -X- _ I-Outcome
leukocytosis. -X- _ I-Outcome
In -X- _ I-Outcome
addition -X- _ I-Outcome
, -X- _ I-Outcome
it -X- _ I-Outcome
can -X- _ I-Outcome
lead -X- _ I-Outcome
to -X- _ I-Outcome
hospitalization -X- _ I-Outcome
( -X- _ I-Outcome
length -X- _ I-Outcome
of -X- _ I-Outcome
stay -X- _ I-Outcome
: -X- _ I-Outcome
5–7 -X- _ I-Outcome
days -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
complications -X- _ I-Outcome
( -X- _ I-Outcome
e.g. -X- _ I-Outcome
, -X- _ I-Outcome
pneumonia -X- _ I-Outcome
, -X- _ I-Outcome
seizures -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
mortality -X- _ I-Outcome
ranging -X- _ I-Outcome
from -X- _ I-Outcome
5.6 -X- _ I-Outcome
to -X- _ I-Outcome
14.7 -X- _ I-Outcome
% -X- _ I-Outcome
. -X- _ O
Other -X- _ O
observations -X- _ O
indicate -X- _ O
that -X- _ O
diagnosis -X- _ O
is -X- _ O
challenging -X- _ O
because -X- _ O
of -X- _ O
non-specific -X- _ O
clinical -X- _ O
symptoms. -X- _ O
Specifically -X- _ O
, -X- _ O
for -X- _ O
obstetricians -X- _ O
and -X- _ O
gynecologists -X- _ O
, -X- _ O
the -X- _ O
information -X- _ O
available -X- _ O
for -X- _ O
making -X- _ O
informed -X- _ O
decisions -X- _ O
on -X- _ O
the -X- _ O
prevention -X- _ O
of -X- _ O
neonatal -X- _ B-Intervention
pertussis -X- _ I-Intervention
is -X- _ O
unreliable. -X- _ O
Maternal -X- _ B-Outcome
immunization -X- _ I-Outcome
against -X- _ I-Outcome
pertussis -X- _ I-Outcome
during -X- _ I-Outcome
late -X- _ I-Outcome
stages -X- _ I-Outcome
of -X- _ I-Outcome
pregnancy -X- _ I-Outcome
has -X- _ I-Outcome
proven -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
efficacious -X- _ I-Outcome
and -X- _ I-Outcome
well -X- _ I-Outcome
tolerated. -X- _ I-Outcome
A -X- _ O
high -X- _ O
burden -X- _ O
of -X- _ O
neonatal -X- _ B-Intervention
pertussis -X- _ I-Intervention
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
its -X- _ O
complications -X- _ O
, -X- _ O
is -X- _ O
observed -X- _ O
in -X- _ O
South -X- _ B-Patient
and -X- _ I-Patient
Southeast -X- _ I-Patient
Asian -X- _ I-Patient
countries. -X- _ I-Patient
There -X- _ O
is -X- _ O
a -X- _ O
need -X- _ O
to -X- _ O
intensify -X- _ O
efforts -X- _ O
to -X- _ O
protect -X- _ O
this -X- _ O
vulnerable -X- _ O
population -X- _ O
with -X- _ O
maternal -X- _ O
vaccination. -X- _ O
Funding -X- _ O
: -X- _ O
GlaxoSmithKline -X- _ O
Biologicals -X- _ O
SA -X- _ O
Plain -X- _ O
Language -X- _ O
Summary -X- _ O
: -X- _ O
Plain -X- _ O
language -X- _ O
summary -X- _ O
available -X- _ O
for -X- _ O
this -X- _ O
article. -X- _ O
Please -X- _ O
see -X- _ O
Fig. -X- _ O
1 -X- _ O
and -X- _ O
the -X- _ O
following -X- _ O
link -X- _ O
: -X- _ O
https -X- _ O
: -X- _ O
/ -X- _ O
/ -X- _ O
doi.org -X- _ O
/ -X- _ O
10.6084 -X- _ O
/ -X- _ O
m9.figshare.7951187 -X- _ O
. -X- _ O

